Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Vaccine Delivery Devices Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The vaccine delivery devices market has experienced substantial expansion in recent times. Projections indicate its value will increase from $7.01 billion in 2025 to $7.72 billion in 2026, at a compound annual growth rate (CAGR) of 10.1%. Historically, this growth has been influenced by factors such as the broadening of national immunization programs, an increase in worldwide vaccine manufacturing capabilities, the escalating occurrence of infectious diseases, advancements in cold-chain logistics, and the extensive adoption of traditional syringe-based delivery methods.
The market size for vaccine delivery devices is projected to experience robust growth in the coming years. It is anticipated to reach $10.9 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period can be attributed to the increasing development of next-generation vaccines, a rising demand for self-administration devices, the expansion of pandemic preparedness programs, growing investments in vaccine accessibility technologies, and an increased focus on dose accuracy and compliance. Major trends expected in this period include the increasing adoption of needle-free injection technologies, a rising demand for microneedle patch delivery systems, the growing use of alternative vaccine administration routes, the expansion of mass immunization programs, and an enhanced focus on patient comfort and safety.
Get A Free Sample Report With In-Depth Market Insights:
Vaccine Delivery Devices Market Development Factors: What’s Supporting Demand?
The anticipated expansion of the vaccine delivery devices market is linked to the rising occurrence of infectious diseases. These diseases are ailments resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, capable of transmission among people, animals, or via polluted settings. Several factors contribute to the surge in infectious diseases, including swift urbanization, more frequent international travel, environmental shifts due to climate change, and growing population densities, all of which aid pathogen spread. Vaccine delivery devices play a crucial role in public health by facilitating the effective and secure administration of vaccines, thereby bolstering community immunity and limiting the dissemination of infectious agents. An illustrative example comes from November 2024, where the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for global public health, reported an estimated 10.3 million measles cases worldwide in 2023, marking a 20% rise over 2022 figures. Consequently, the expanding occurrence of infectious diseases acts as a primary catalyst for the growth of the vaccine delivery devices market.
Vaccine Delivery Devices Market Segment Breakdown: Which Categories Lead On Revenue?
The vaccine delivery devices market covered in this report is segmented –
1) By Type Of Device: Needle Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches And Microinjectors
2) By Route Of Administration: Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination, Other Vaccinations
3) By End Users: Hospitals, Clinics, Other End Users
Subsegments:
1) By Needle Free Injection Systems: Spring-Based Injectors, Gas-Driven Injectors, Hybrid Injectors
2) By Oral Delivery Systems: Oral Tablets And Capsules, Oral Sprays, Oral Solutions
3) By Nasal Delivery Systems: Nasal Sprays, Nasal Drops, Nasal Powder Systems
4) By Jet Injectors: Pneumatic Jet Injectors, Electromechanical Jet Injectors
5) By Microneedle Patches And Microinjectors: Dissolvable Microneedles, Solid Microneedles, Microinjector Devices
Vaccine Delivery Devices Market Transformation Trends: What Innovations Are Driving Change?
Leading companies within the vaccine delivery devices market are prioritizing the creation of advanced solutions, including innovative intradermal delivery systems, aimed at boosting vaccine effectiveness and reducing waste. An intradermal delivery system is a technology designed to administer vaccines directly into the dermal layer, where a high concentration of immune cells helps elicit stronger immunogenic responses even with lower vaccine volumes. For example, in July 2025, Terumo Corporation, a Japan-based medical technology company, unveiled the Immucise Intradermal Injection System. This vertical-puncture device, fitted with a 33G needle, ensures accurate intradermal delivery. This advancement contributes to consistent wheal formation with minimal leakage, offers improved accuracy for intradermal injections compared to the traditional Mantoux technique, and facilitates a significant reduction in the necessary vaccine dosage. By promoting stronger immunogenicity, optimizing resource deployment, and easing operational hurdles, the Immucise system ultimately improves vaccination efficiency and helps streamline healthcare workflows.
Vaccine Delivery Devices Market Competitive Overview And Top Companies
Major companies operating in the vaccine delivery devices market are Johnson & Johnson, Sanofi S.A., 3M Company, GlaxoSmithKline plc, Becton Dickinson and Company, INOVIO Pharmaceuticals Inc., Terumo Corporation, SCHOTT AG, Vaxxas Inc., PharmaJet Inc., Enesi Pharma Limited, NanoPass Technologies Ltd., Gerresheimer AG, West Pharmaceutical Services Inc., Nemera, SHL Medical AG, Portal Instruments Inc., ApiJect Systems Corp., Credence MedSystems Inc., Zosano Pharma Corporation
View The Full Vaccine Delivery Devices Market Report:
Vaccine Delivery Devices Market Leading Geography: Which Region Contributes The Most Revenue?
North America was the largest region in the vaccine delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
